Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Hereditary Cancer Testing Market Size Forecast: How Big Could The Market Get By 2030?
The hereditary cancer testing market has witnessed rapid expansion over recent years. This market is projected to grow from $4.75 billion in 2025 to $5.3 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.6%. In the past, this growth was primarily due to factors such as increased public awareness of hereditary cancer risks, the widespread availability of next-generation sequencing platforms, the broadening of diagnostic laboratory networks, an uptick in physician recommendations for genetic testing, and the development of personalized risk assessment models.
The hereditary cancer testing market size is anticipated to experience substantial growth in the next few years, reaching $8.02 billion by 2030, at a compound annual growth rate (CAGR) of 10.9%. This expansion during the forecast period can be attributed to the broader implementation of population-scale genetic screening, the increasing application of AI-driven genomic analysis, a rise in preventive oncology initiatives, a growing need for cost-effective testing solutions, and strengthened regulatory support for genetic diagnostics. Noteworthy trends for this period include the increased adoption of multi-gene panel testing, a heightened demand for early cancer risk detection, the growing utilization of advanced genetic sequencing technologies, the expansion of preventive testing programs, and an improved integration of clinical decision support tools.
Get A Free Sample Report With In-Depth Market Insights:
Hereditary Cancer Testing Market Growth Factors: What’s Supporting Expansion?
The escalating burden of cancer is anticipated to propel the hereditary cancer testing market forward. Cancer refers to a group of diseases characterized by the uncontrolled and abnormal proliferation of cells, which can invade and disseminate to other tissues and parts of the body. In a healthy organism, cells typically adhere to a regulated cycle of growth, division, and death. Hereditary cancer testing plays a crucial role in addressing the comprehensive impact of cancer by identifying individuals with a genetic predisposition to specific cancers. By evaluating inherited mutations and familial risk factors, this testing assists in pinpointing individuals at higher risk, thereby enabling early intervention, personalized treatment strategies, and proactive preventive measures. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in Australia the number of cancer cases diagnosed increased from 160,570 in 2022 to 164,694 in 2023, reflecting a notable rise over the year. This upward trend underscores the growing prevalence of cancer within the country. Consequently, an increase in the overall cancer burden is driving the hereditary cancer testing market.
Hereditary Cancer Testing Market Segment Breakdown: Which Categories Lead On Revenue?
The hereditary cancer testing market covered in this report is segmented –
1) By Test Type: Multi Panel Test, Single-Site Genetic Test
2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications
3) By End user: Hospital, Clinics, Diagnostic Centers
Subsegments:
1) By Multi Panel Test: Comprehensive Genetic Panels, Targeted Gene Panels
2) By Single-Site Genetic Test: Specific Gene Testing, Familial Mutation Testing
Hereditary Cancer Testing Market Trends Shaping Long-Term Demand
Companies in the hereditary cancer testing market are prioritizing innovative technologies, such as molecular diagnostic tumor testing, to improve accuracy, enhance patient outcomes, and tailor treatment strategies. This testing method involves analyzing a tumor’s genetic and molecular traits to guide treatment decisions and predict future outcomes. For example, in February 2023, Chubb Business Services India Private Limited, an India-based global insurance company, introduced Cancer Advocate Plus. The program incorporates genetics-based testing to detect inherited genes that elevate cancer risk. This proactive methodology enables individuals to comprehend their predisposition to various cancers, thereby supporting early intervention and personalized care approaches.
Hereditary Cancer Testing Market Leading Players And Competitive Positioning
Major companies operating in the hereditary cancer testing market are Centogene NV, Ambry Genetics Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated Regional and University Pathologists Inc., 4baseCare, Biocartis Group NV, F. Hoffmann-La Roche AG, Medgenome Pvt. Ltd., Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies PLC, PerkinElmer Inc.
View The Full Hereditary Cancer Testing Market Report:
Hereditary Cancer Testing Market Regional Analysis And Top Geography
North America was the largest region in the hereditary cancer testing market in 2025. The regions covered in the hereditary cancer testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
